Organization
Brian Jonas
3 clinical trials
Clinical trial
Phase II Study of Venetoclax With Alternative Hypomethylating Agent for Patients With Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure: A University of California Hematologic Malignancies Consortium ProtocolStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Phase I Study of Uproleselan Combined With Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients With Treatment Naive Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Phase 2 Study of Ibrutinib and Blinatumomab in Relapsed and Refractory B-Cell Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2025-02-01